Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains
- 15 October 1982
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (20) , 3193-3199
- https://doi.org/10.1016/0006-2952(82)90549-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.Published by Wiley ,1981
- GENETIC IMPAIRMENT OF PHENFORMIN METABOLISMThe Lancet, 1980
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineEuropean Journal of Clinical Pharmacology, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- A study of the debrisoquine hydroxylation polymorphism in a Nigerian populationXenobiotica, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977